Anke Gold tells FoodNavigator that nutrient-dense foods built for smaller GLP-1 portions fill gaps for everyone, and expects micronutrients to join protein and fiber next.
Recap by typeshit. Full story at FoodNavigator.com.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
The writer cites a Gallup survey putting about 11 percent of Americans on GLP-1s and argues the real share is likely higher, and wants use discussed openly.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
The Prestige cites NPR's review of 190,000 GLP-1 adverse event filings since 2024, which counted about 2,000 pancreatitis cases and 1,000 reports of sudden blindness.
Users most often reported increased appetite, unlike the stomach issues seen in trials. The authors say it proves nothing causal and only flags leads to test.
Loading…